Özet:

Mallory-Weiss syndrome is responsible for up to 1-4% of upper gastrointestinal system bleeding. Most of the Mallory-Weiss syndrome is seen with mild bleeding in a way that does not require specific endoscopic treatment; however, in some cases, bleeding may be from a subscription. Unlike ulceral bleeding, endoscopic treatment in Mallory-Weiss syndrome has not been very well standardized. In this study, we aimed at comparing the demographic characteristics of our own events, the endoscopic treatments applied and the clinical observations of patients. Tools and Methods: The Higher Special Education and Research Hospital of Turkey, the Endoscopy Unit, examined the patients diagnosed with Mallory-Weiss syndrome between 2010-2017 as retrospective. Results: A total of 37 patients (man/woman: 29/8, average age: 63,4±19,4) were included in the study. The number of patients who were diagnosed during the Mallory-Weiss laser endoscopy was 15 and 27 of them had symptoms of active bleeding. Primary hemostasis was observed in 92.5% of patients. Endoscopic treatments applied to patients with symptoms of active bleeding were adrenaline injection, clips application, heater prob. According to the formation of Mallory-Weiss syndrome, the patients were divided into two groups as patients with and not with iatrogenic Mallory-Weiss syndrome. There was no difference between the groups in terms of the presence of hospitalization, the need to be given erythrosite suspension, the presence of active symptoms of bleeding, the presence of hyatal hernia and the endoscopic treatments applied. A total of 27 patients were applied clips; 19 of these patients were applied only clips, while 8 were applied adrenaline with clips. Mortality is not observed in our patients. The result: although most patients with Mallory-Weiss syndrome are clinically benign, these patients should be kept in mind that they will be accompanied by severe bleeding. Hemoclips are an effective and safe method of endoscopic treatment.

Anahtar Kelimeler: